Your browser doesn't support javascript.
loading
Prevalence of fetomaternal Rhesus incompatibility at the tertiary care hospital: a cross-sectional study.
Nyakio, Olivier; Kibukila, Fabrice; Suvvari, Tarun Kumar; Bhattacharjee, Priyadarshini; Akilimali, Aymar; Mukwege, Denis.
Afiliação
  • Nyakio O; Faculty of Medicine, Evangelic University in Africa.
  • Kibukila F; Faculty of Medicine, Official University of Bukavu, Bukavu.
  • Suvvari TK; Society for Maternal-Fetal Medicine (SMFM), Washington, DC.
  • Bhattacharjee P; Faculty of Medicine, Official University of Bukavu, Bukavu.
  • Akilimali A; Department of Medicine, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
  • Mukwege D; Department of Clinical Medicine, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
Ann Med Surg (Lond) ; 86(4): 1901-1905, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38576979
ABSTRACT

Background:

Fetomaternal Rhesus incompatibility is a medical condition that affects the pregnant woman [of blood group (A, B, AB, O) and a negative Rhesus] and the foetus (of positive Rhesus). The objective of this study is to determine the prevalence and to present the clinical characteristics of fetomaternal Rhesus incompatibility in a tertiary care hospital.

Methods:

The authors conducted a retrospective cross-sectional study and 37 participants were recorded during the study period of 4 years.

Results:

A total of 11 898 pregnant women admitted to the maternity and 37 of them (women with blood groups A, B, AB or O and with a negative Rhesus) participated in our study, including a frequency of 0.31%. Thirty cases of fetomaternal Rhesus incompatibility were recorded in new-borns. 27 (73%) of the women are from the urban region and the age group between 21 and 25 is the most affected with 37.8%. Twenty-two (59.5%) of pregnant women have blood group O (and negative Rhesus) and primiparous women are the most affected with 64.9%. For the discovery of allo-immunization, 43.2% of women discovered it during the second pregnancy and 48.7% women received a single infusion of Anti-D serum during the first pregnancy. Twelve (40%) new-borns developed jaundice as a perinatal prognosis.

Conclusion:

Fetomaternal Rhesus incompatibility remains a major problem of maternal health because it is likely to lead to the formation of antibodies in women, which by crossing the placental barrier, they destroy red blood cells and thus cause serious complications.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2024 Tipo de documento: Article